E-mail a Wiley Online Library Link

Gianni Bisogno, Riccardo Riccardi, Antonio Ruggiero, Giampaolo Arcamone, Arcangelo Prete, Gianmarco Surico, Massimo Provenzi, Patrizia Bertolini, Paolo Paolucci and Modesto Carli Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma Cancer 106

Version of Record online: 20 DEC 2005 | DOI: 10.1002/cncr.21629

A phase II study of irinotecan administered intravenously every day for 5 days in 2 consecutive weeks, conducted in pediatric patients with relapsed soft tissue sarcoma, demonstrated an interesting response rate in a population of heavily pretreated patients, especially in the subset of patients with peripheral primitive neuroectodermal tumor.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field